Evidence map›Paper›PMID 16789836›Full record

ArticlePLoS pathogens2006

Host-specific response to HCV infection in the chimeric SCID-beige/Alb-uPA mouse model: role of the innate antiviral immune response.

Kathie-Anne Walters, Michael A Joyce, Jill C Thompson, Maria W Smith, Matthew M Yeh, Sean Proll, Lin-Fu Zhu, T J Gao, Norman M Kneteman, D Lorne Tyrrell and 1 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 76 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Murine Models of Hepatitis A Virus Infection.Cold Spring Harbor perspectives in medicine · 2019
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Kathie-Anne WaltersDepartment of Microbiology, School of Medicine, University of Washington, Seattle, Washington, USA. kathiw@u.washington.edu
Michael A Joyce
Jill C Thompson
Maria W Smith
Matthew M Yeh
Sean Proll
Lin-Fu Zhu
T J Gao
Norman M Kneteman
D Lorne Tyrrell
Michael G Katze
University of Washington · USUniversity of Alberta · CA

Funding

INCIDENCE OF HIV INFECTIONS IN A COHORT OF IV DRUG USERSR01DA012568 · NIDA · JOHNS HOPKINS UNIVERSITY · PI MEHTA, SHRUTI H · 1999 to 2017
$15.5M
The Progression of Hepatitis C Among IDUs with HIVR01DA016078 · NIDA · JOHNS HOPKINS UNIVERSITY · PI BALAGOPAL, ASHWIN, THOMAS, DAVID L · 2002 to 2016
$10.9M
NATURAL HISTORY OF HIV INFECTION IN INJECTION DRUG USERSR37DA004334 · NIDA · JOHNS HOPKINS UNIVERSITY · PI KIRK, GREGORY D · 1997 to 2006
$9.0M
HIV replication and cell injury in cultured hepatocytesU19AI048214 · NIAID · UNIVERSITY OF WASHINGTON · PI FAUSTO, NELSON · 2000 to 2004
$3.9M
Pathogenesis of Hepatocellular CarcinomasR01CA074131 · NCI · UNIVERSITY OF WASHINGTON · PI FAUSTO, NELSON · 1997 to 2010
$3.1M
NCI NIH HHS 5R01CA074131NCI NIH HHS R01 CA074131NIAID NIH HHS 5U19AI48214NIAID NIH HHS U19 AI048214NIDA NIH HHS 1P30DA01562501NIDA NIH HHS 1R37DA004334NIDA NIH HHS R01 DA012568NIDA NIH HHS R01 DA016078NIDA NIH HHS R01DA12568NIDA NIH HHS R01DA16078NIDA NIH HHS R37 DA004334PHS HHS 5R01A1049168
6 · The paper itself

Abstract

The severe combined immunodeficiency disorder (SCID)-beige/albumin (Alb)-urokinase plasminogen activator (uPA) mouse containing a human-mouse chimeric liver is currently the only small animal model capable of supporting hepatitis C virus (HCV) infection. This model was utilized to characterize the host transcriptional response to HCV infection. The purpose of these studies was to investigate the genetic component of the host response to HCV infection and also to distinguish virus-induced gene expression changes from adaptive HCV-specific immune-mediated effects. Gene expression profiles from HCV-infected mice were also compared to those from HCV-infected patients. Analyses of the gene expression data demonstrate that host factors regulate the response to HCV infection, including the nature of the innate antiviral immune response. They also indicate that HCV mediates gene expression changes, including regulation of lipid metabolism genes, which have the potential to be directly cytopathic, indicating that liver pathology may not be exclusively mediated by HCV-specific adaptive immune responses. This effect appears to be inversely related to the activation of the innate antiviral immune response. In summary, the nature of the initial interferon response to HCV infection may determine the extent of viral-mediated effects on host gene expression.

Indexed as

ChimeraImmunity, InnateAlbuminsAnimalsAntibodies, ViralGene Expression ProfilingHepatitis CHepatocytesHumansLipid MetabolismLiverMiceMice, SCIDOxidative StressSignal TransductionUrokinase-Type Plasminogen ActivatorAlbuminsAntibodies, ViralUrokinase-Type Plasminogen Activator

Identifiers

PMID16789836
PMCPMC1480599
OpenAlexW1996064622

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.